Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized
by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to …

Pulmonary fibrosis is characterized by an inflammatory response that includes
macrophages, neutrophils, lymphocytes, and mast cells. The purpose of this study was to …

Background Persistence of myofibroblasts is believed to contribute to the development of
fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor β1 (TGFβ1) …

The purpose of this study was to evaluate integrated 18F-FDG PET/CT in patients with
idiopathic pulmonary fibrosis (IPF) and diffuse parenchymal lung disease (DPLD). Methods …

Background Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease with limited
treatment options. Plumbagin (PL) is an herbal extract with diverse pharmacological effects …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by severe,
progressive fibrosis. Roles for inflammation and oxidative stress have recently been …

Pirfenidone (PFD) is one of the pyridine family components with anti-inflammatory,
antifibrotic effects and US FDA approved for the treatment of idiopathic pulmonary fibrosis …

Lonicera japonica (Caprifoliaceae) has been known as an anti-inflammatory herb in
traditional Chinese medicine for thousands of years and is used constantly for upper …

Activated fibroblasts are the central effector cells of the progressive fibrotic process in
idiopathic pulmonary fibrosis (IPF). Characterizing the genomic phenotype of isolated …

Despite an increase in the knowledge of mechanisms and mediators involved in pulmonary
fibrosis, there are no successful therapeutics available. Lipoxins (LX) and their 15-epimers …